Thromb Haemost 1977; 37(01): 017-028
DOI: 10.1055/s-0038-1649197
Original Article
Schattauer GmbH

Platelet Interaction with Collagen Fibrils in Flowing Blood

II. Impaired Adhesion-Aggregation in Bleeding Disorders. A Comparison with Subendothelium
Hans R. Baumgartner
1   Pharmaceutical Research Department F. Hoffmann-La Roche and Co., Ltd. CH-4002 Basel, Switzerland
2   Department of Medicine (Division of Hematology) Roosevelt Hospital and Columbia University College of Physicians and Surgeons, New York City, U.S.A.
,
Thomas B. Tschopp
1   Pharmaceutical Research Department F. Hoffmann-La Roche and Co., Ltd. CH-4002 Basel, Switzerland
2   Department of Medicine (Division of Hematology) Roosevelt Hospital and Columbia University College of Physicians and Surgeons, New York City, U.S.A.
,
Harvey J. Weiss
1   Pharmaceutical Research Department F. Hoffmann-La Roche and Co., Ltd. CH-4002 Basel, Switzerland
2   Department of Medicine (Division of Hematology) Roosevelt Hospital and Columbia University College of Physicians and Surgeons, New York City, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 18 June 1976

Accepted 24 July 1976

Publication Date:
03 July 2018 (online)

Summary

Anticoagulated whole blood from patients and control subjects was circulated through an annular perfusion chamber in which the fibrillar collagen of α chymotrypsin-digested subendothelium and intact subendothelium were exposed. The blood flow conditions corresponded to those in arteries (830 sec–1 wall shear rate). Platelet surface interaction was measured mor-phometrically.

Decreased adhesion to fibrillar collagen associated with normal spreading and normal adhesion-induced formation of platelet thrombi was found with blood of patients with von Willebrand’s disease and the Bernard Soulier Syndrome, indicating a defect in the initial attachment reaction of platelets with collagen. Platelets of patients with thrombasthenia did normally adhere to the collagen fibrils and also lost their subcellular organelles during this reaction, but they totally failed to adhere to each other. In storage pool disease platelet thrombus formation was consistently inhibited whereas adhesion and spreading was inhibited in some patients and normal in others. In contrast adhesion was always normal after ingestion of aspirin which consistently caused a marked inhibition of platelet thrombi. These findings correspond – in essence – to those previously described on intact subendothelium. However, the observed defects are more pronounced on the fibrillar collagen than on intact subendothelium.

 
  • References

  • 1 Baumgartner H.R. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvascular Research 1973; 5: 167
  • 2 Baumgartner H.R. Morphometric quantitation of adherence of platelets to an artificial surface and components of connective tissue. Thrombosis et Diathesis Haemorrhagica. Supplementum 1974; 60: 39
  • 3 Baumgartner H.R. Platelet interaction with collagen in flowing blood. I. Reaction of human platelets with α chymotrypsin-digested subendothelium. Thrombosis and Haemostasis 1977; 37: 1
  • 4 Baumgartner H.R, Haudenschild C. Adhesion of platelets to subendothelium. Annals of the New York Academy of Sciences 1972; 201: 22
  • 5 Baumgartner H.R, Muggli R. Effect of acetylsalicylic acid on platelet adhesion to subendothelium and on the formation of mural platelet thrombi. Thrombosis et Diathesis Haemorrhagica. Supplementum 1974; 60: 345
  • 6 Baumgartner H.R, Muggli R, Tschopp T.B, Turitto V.T. Platelet adhesion, release and aggregation in flowing blood: Effects of surface properties and platelet function. Thrombosis and Haemostasis 1976; 35: 124
  • 7 Baumgartner H.R, Stemerman M.B, Spaet T.H. Adhesion of blood platelets to subendothelial surface: Distinct from adhesion to collagen. Experientia 1971; 27: 283
  • 8 Cazenave J.P, Packham M.A, Guccione M.A, Mustard J.F. Inhibition of platelet adherence to a collagen-coated surface by non-steroidal anti-inflammatory drugs, pyrimidopyrimidine and tricyclic compounds and lidocaine. Journal of Laboratory and Clinical Medicine 1974; 83: 797
  • 9 Cazenave J.P, Packham M.A, Guccione M.A, Mustard J.F. Inhibition of platelet adherence to damaged surface of rabbit aorta. Journal of Laboratory and Clinical Medicine 1975; 86: 551
  • 10 Holmsen H, Day H.J, Stormorken H. The blood platelet release reaction. Scandinavian Journal of Haemotology. Supplementum 1969; 8: 1
  • 11 Meyer D, Jenkins C.S.P, Dreyfus M.D, Larrieu M.J. An experimental model for von Willebrand’s disease. Nature 1973; 243: 293
  • 12 Reimers H.J, Kinlough-Rathbone R.L, Cazenave J.P, Senyi A.F, Hirsh J, Packham M.A, Mustard J.F. In vitro and in vivo functions of thrombin-treated platelets. Thrombosis and Haemostasis 1976; 35: 151
  • 13 Sheppard B.L. The effect of acetylsalicylic acid on platelet adhesion in the injured abdominal aorta. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences 1972; 57: 319
  • 14 Smith J.B, Willis A.L. Selective inhibition of synthesis of prostaglandin in human platelets. Nature 1971; 231: 235
  • 15 Ts’ao C. Ultrastructural study of the effect of aspirin on in vitro platelet-collagen interaction and platelet adhesion to injured intima in the rabbit. American Journal of Pathology 1970; 59: 327
  • 16 Tschopp T.B, Baumgartner H.R. Enzymatic removal of ADP from plasma: Unaltered platelet adhesion but reduced aggregation on subendothelium and collagen fibrils. Thrombosis and Haemostasis 1976; 35: 334
  • 17 Tschopp T.B, Baumgartner H.R. Delayed adhesion to subendothelium and defective aggregation of platelets from rats with storage pool disease (SPD) Thrombosis et Diathesis Haemor-rhagica 1975; 34: 600
  • 18 Tschopp T.B, Weiss H.J, Baumgartner H.R. Decreased adhesion of platelets to subendothelium in von Willebrand’s disease. Journal of Laboratory and Clinical Medicine 1974; 83: 296
  • 19 Tschopp T.B, Weiss H.J, Baumgartner H.R. Interaction of thrombasthenic platelets with subendothelium. Normal adhesion, absent aggregation. Experientia 1975; 31: 113
  • 20 Turitto V.T, Baumgartner H.R. Effect of temperature on platelet interaction with subendothelium exposed to flowing blood. Haemostasis 1974; 3: 224
  • 21 Turitto V.T, Baumgartner H.R. Platelet interaction with subendothelium in a perfusion system. Physical role of red blood cells. Microvascular Research 1975; 9: 335
  • 22 Weiss H.J. Aspirin ingestion compared with bleeding disorders – Search for a useful platelet an-tiaggregant. Blood 1970; 35: 333
  • 23 Weiss H.J. Platelet physiology and abnormalities of platelet function. Two Parts. New England Journal of Medicine 1975; 293 (531) 580
  • 24 Weiss H.J, Aledort L.M. Impaired platelet/connective-tissue reaction in man after aspirin ingestion. Lancet 1967; 2: 495
  • 25 Weiss H.J, Chervenick P.A, Zalusky R, Faktor A. A familial defect in platelet function associated with impaired release of adenosine diphosphate. New England Journal of Medicine 1969; 281: 1264
  • 26 Weiss H.J, Tschopp T.B, Baumgartner H.R. Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion – a comparison with von Willebrand’s disease. New England Journal of Medicine 1975; 293: 619
  • 27 Weiss H.J, Tschopp T.B, Baumgartner H.R, Sussman I.I, Johnson M.M, Egan J.J. Decreased adhesion of giant (Bernard Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in haemostasis. American Journal of Medicine 1974; 57: 920
  • 28 Weiss H.J, Willis A.L, Kuhn D, Brand H. Prostaglandin E2 potentiation of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion. British Journal of Haematology 1976; 32: 257
  • 29 Willis A.L. An enzymatic mechanism for antithrombotic and antihemostatic actions of aspirin. Science 1974; 183: 325